|
|
 |
 printable version
CIPIH Open Forum
1 June 2005
World Health Organization
Executive Board Room
Geneva, Switzerland
Presentations
::
Opening Speech (translated from French) [pdf 73kb]
Ms Ruth Dreifuss, President of the Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH)
::
They need new drugs, vaccines and diagnosis now: reality of neglected diseases [pdf 1.52Mb]
Bernard Pecoul, DNDi
::
Policies to build innovative capacity [pdf 7.58Mb]
Carlos Morel, Fiocruz
::
Availability, Accessibility and Affordability: the challenge of diseases of poverty [pdf 329kb]
Gill Samuels, Pfizer
::
The IP System, R&D and Access -- and What is Needed [pdf 344kb]
Harvey Bale, IFPMA
::
Two ideas regarding Innovation and Access [pdf 239kb]
James Love, CPTech
::
Research Tool Patents and Biomedical Research: Findings and Implications [pdf 293kb]
John Walsh, University of Tokyo/University of Illinois at Chicago
::
The new world of neglected disease drug R&D [pdf 453kb]
Mary Moran, Wellcome Trust
::
Building Innovative Capacity in Developing Countries [pdf 2.17Mb]
Michael Rawlins, National Institute for Health and Clinical Excellence
and Professor of ClinicalPharmacology, University of Newcastle
::
Access to Medicine: A Novartis Experiment [pdf 9.67Mb]
Paul Herrling, Novartis
::
National legislative changes and the TRIPs Agreement: A case study of South Africa [pdf 379kb]
Tenu Avafia, tralac
::
What are the current trends in terms of the global burden of disease and how should they inform R&D and financing prirorities? [pdf 3.33Mb]
Open Forum Workshop Results, Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH)
|
|
